Connect With the Organizations Shaping the Future of Drug Development in Rare Neurology

Rare genetic epilepsies are rapidly becoming one of the most attractive opportunities in neuroscience drug development. As companies invest in ASOs, gene therapies, RNA medicines, precision small molecules, and other disease-modifying approaches, demand continues to grow for specialist partners capable of accelerating development, generating evidence, improving trial execution, and supporting commercialization.

The Rare Epilepsy & DEE Drug Development Summit provides direct access to senior decision-makers actively seeking innovative solutions across translational research, clinical development, biomarker strategy, patient identification, trial execution, regulatory planning, and commercialization.

Screenshot-2025-05-23-093902-768x515-1

What to Expect?

Showcase Your Expertise

Demonstrate how your solutions address the industry's most pressing development challenges

Engage True Decision-Makers

Connect directly with executives and leaders responsible for outsourcing, partnerships, and strategic investments

Gain Competitive Intelligence

Understand emerging trends, investment priorities, and future areas of innovation

Raise Brand Visibility

Position your organization alongside industry leaders including Biogen, Lundbeck, Ionis Pharmaceuticals, Jazz Pharmaceuticals, and GRIN Therapeutics

Generate Qualified Opportunities

Build relationships with organizations actively progressing therapies through preclinical and clinical development

Key Services & Solutions

Our highly specific audience of biopharma executives are actively seeking specialist service and solution providers in the following areas:

  • Preclinical Models & Translational Research
  • Human iPSC & Organoid Platforms
  • Rare Disease Clinical CROs
  • EEG Services & Neurophysiology Solutions
  • Biomarker Development
  • Regulatory & Market Access Consulting
  • Patient Identification & Recruitment
  • Clinical Data & Digital Endpoint Technologies
Why-Partner-Ophthalmic-1

Attending Companies Include

Hear What Our Past Sponsors Have to Say

bruker-logo

Big enough to make it worthwhile in terms of making new connections but small enough to make networking possible. Lots of nice interaction during the sessions

Jonathan Nassi, Senior Director Translational Science, Bruker

Screen-Shot-2021-09-10-at-5.12.08-pm

A meeting with like minded scientists who are all excited about neuropsychiatry

Alishah Suleman, Principal Investigator, Clerkenwell Health

Audience Composition

Company Type

Placeholder Image

Attendee Seniority

Placeholder Image

Get in Touch

Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.

Name Surname

Job Title
Event/ Topic Area Name

Why-Partner-6-768x432-1
Maintain Your Competitive Edge

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.

Maintain-Your-Competitive-Edge-768x432-1
Network With Decision-Makers

Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.

Showcase-Your-Capabilities-768x432-1
Showcase Your Capabilities

Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.